Pages

Wednesday, November 15, 2017

Drugmaker Acorda Plunges After Deaths in Parkinson's Trial

... U.S. regulators said they wouldn't review Acorda's application to sell Inbrija because of questions about the Ardsley, New York-based company's manufacturing. (Updates share price in the fifth paragraph. An earlier version of this story corrected ...
http://ift.tt/2yJis6e

No comments:

Post a Comment